Table 1 SOX2 expression in primary carcinoma (DCIS and invasive carcinoma) and lymph node samples
From: Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
| Â | N total | Score 0 | Score 1 | Score 2 | Score 3 |
|---|---|---|---|---|---|
DCIS | 9 | 5 (55.6%) | 1 (11.1%) | 2 (22.2%) | 1 (11.1%) |
Invasive Carcinoma | 86 | 62 (72%) | 11 (12.8%) | 5 (5.8%) | 8 (9.3%) |
Lymph nodes | 18 | 9 (50%) | 4 (22.2%) | 1 (5.5%) | 4 (22.2%) |